|
(Rac)-BAY1238097
|
(RAC)-BAY1238097
|
1564268-19-4
|
|
GSK1379725A
|
1802251-00-8
|
1802251-00-8
|
|
Sirt2-IN-1
|
SIRT2-IN-1
|
1862238-00-3
|
|
HJB97
|
|
2093391-24-1
|
|
INCB054329
|
1628607-64-6
|
1628607-64-6
|
|
CF53
|
CF53
|
1808160-52-2
|
|
SIRT5 inhibitor 1
|
2166487-21-2
|
2166487-21-2
|
|
PKC-theta inhibitor
|
MDK-8650
|
736048-65-0
|
|
SGC-iMLLT
|
SGC-IMLLT
|
2255338-25-9
|
|
Nudifloramide
|
1-甲基-6-氧代吡啶-3-甲酰胺
|
701-44-0
|
|
BI-9321 trihydrochloride
|
BI-9321 trihydrochloride
|
2387510-87-2
|
|
MRK-740
|
化合物 MRK-740
|
2387510-80-5
|
|
UBCS039
|
UBCS039
|
358721-70-7
|
|
PIN1 inhibitor API-1
|
O6-[4-(TRIFLUOROACETAMIDOMETHYL)BENZYL]GUANINE
|
680622-70-2
|
|
GSK467
|
化合物GSK467
|
1628332-52-4
|
|
TCS 21311
|
TCS21311; TCS-21311
|
1260181-14-3
|
|
GNE-049
|
化合物 T15397
|
1936421-41-8
|
|
DCP-LA
|
DCP-LA
|
28399-31-7
|
|
DCPLA-ME
|
DCPLA-ME
|
56687-67-3
|
|
EB-47 dihydrochloride
|
EB47; EB-47
|
1190332-25-2
|
|
BYK204165
|
4-((1-甲基-1H-吡咯-2-基)亚甲基)异喹啉-1,3(2H,4H)-二酮
|
1104546-89-5
|
|
GNE-781
|
GNE-781
|
1936422-33-1
|
|
GeA-69
|
N-(2-(9H-咔唑-1-基)苯基)乙酰胺
|
2143475-98-1
|
|
JFD00244
|
JFD00244
|
96969-83-4
|
|
Valemetostat tosylate
|
VALEMETOSTAT TOSYLATE
|
1809336-93-3
|
|
UNC0224
|
UNC 0224
|
1197196-48-7
|
|
UNC0321
|
UNC0321
|
1238673-32-9
|
|
EZM 2302
|
GSK 3359088
|
1628830-21-6
|
|
E-7386
|
E-7386
|
1799824-08-0
|
|
EBI-2511
|
化合物EBI-2511
|
2098546-05-3
|
|
CBP/EP300-IN-1
|
Benzoic acid, 3-[[(1-acetyl-5-methoxy-1H-indol-3-yl)carbonyl]amino]-4-fluoro-, 1,1-dimethylethyl ester
|
2443789-32-8
|
|
Y06036
|
Y06036
|
1832671-96-1
|
|
Y06137
|
Y06137
|
2226534-49-0
|
|
EHMT2-IN-2
|
EHMT2-IN-2
|
2230850-47-0
|
|
BRD7-IN-1
|
化合物BRD7-IN-1
|
2448414-48-8
|
|
MT1
|
MT1 BET INHIBITOR
|
2060573-82-0
|
|
ZL0420
|
ZL0420
|
2230496-80-5
|
|
NCGC00247743
|
1435192-04-3
|
1435192-04-3
|
|
BAY1238097
|
BAY1238097
|
1564268-08-1
|
|
(R)-BAY1238097
|
(R)-BAY1238097
|
1564269-85-7
|
|
GNA002
|
GNA002
|
1385035-79-9
|
|
A-395
|
化合物A-395
|
2089148-72-9
|
|
JNJ-64619178
|
CS-2829
|
2086772-26-9
|
|
IACS-9571 hydrochloride
|
IACS-9571 hydrochloride
|
2319611-93-1
|
|
MOZ-IN-2
|
MOZ-IN-2
|
2055397-88-9
|
|
BET bromodomain inhibitor
|
化合物BET BROMODOMAIN INHIBITOR
|
1505453-59-7
|
|
CMPD101
|
CMPD101
|
865608-11-3
|
|
T-3775440 hydrochloride
|
T-3775440盐酸盐
|
1422535-52-1
|
|
Fasudil Hydrochloride
|
盐酸法舒地尔
|
105628-07-7
|
|
PROTAC Sirt2 Degrader-1
|
2MG
|
2098487-75-1
|
|
PF-06726304
|
PF-06726304
|
1616287-82-1
|
|
Seclidemstat
|
SECLIDEMSTAT
|
1423715-37-0
|
|
GSK2807 Trifluoroacetate
|
GSK2807 Trifluoroacetate
|
2245255-66-5
|
|
QC6352
|
QC6352
|
1851373-36-8
|
|
CAY10602
|
1-(4-氟苯基)-3-(苯磺酰基)-1H-吡咯并[2,3-B]喹喔啉-2-胺
|
374922-43-7
|
|
SRT 1720
|
N-[2-[3-(1-哌嗪基甲基)咪唑并[2,1-B]噻唑-6-基]苯基]-2-喹喔啉甲酰胺
|
925434-55-5
|
|
Niraparib hydrochloride
|
MK-4827
|
1038915-64-8
|
|
Niraparib (R-enantiomer)
|
MK-4827 (R-enantioMer)
|
1038915-58-0
|
|
Delcasertib
|
Delcasertib
|
949100-39-4
|
|
SB-218078
|
SB218078
|
135897-06-2
|
|
BAY-299
|
BAY-299
|
2080306-23-4
|
|
GSK8573
|
GSK8573
|
1693766-04-9
|
|
R 59-022
|
化合物 T16709
|
93076-89-2
|
|
Bisindolylmaleimide X hydrochloride
|
BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE)
|
145317-11-9
|
|
ICAM-1-IN-1
|
251994-14-6
|
251994-14-6
|
|
KDM5A-IN-1
|
1905481-36-8
|
1905481-36-8
|
|
A-196
|
1982372-88-2
|
1982372-88-2
|
|
ME0328
|
ME0328
|
1445251-22-8
|
|
BI-7273
|
CS-2327
|
1883429-21-7
|
|
MS049
|
1502816-23-0
|
1502816-23-0
|
|
KDM5-IN-1
|
1628210-26-3
|
1628210-26-3
|
|
TP-472
|
TP-472
|
2079895-62-6
|
|
SGC2085
|
SGC2085
|
1821908-48-8
|
|
Cl-amidine hydrochloride
|
N-[(1S)-1-(氨基羰基)-4 -[(2 - 氯-1-亚氨基乙基氨基]丁基]-苯甲酰胺盐酸盐
|
1373232-26-8
|
|
Hispidin
|
6-[(1E)-2-(3,4-二羟基苯基)乙烯基]-4-羟基-2H-吡喃-2-酮
|
555-55-5
|
|
AZD5153 6-Hydroxy-2-naphthoic acid
|
AZD5153结晶体(API形式)
|
1869912-40-2
|
|
Lin28-let-7a antagonist 1
|
Lin28-IN-1
|
2024548-03-4
|
|
TPOP146
|
2018300-62-2
|
2018300-62-2
|
|
GNE-272
|
1936428-93-1
|
1936428-93-1
|
|
GSK9311
|
1923851-49-3
|
1923851-49-3
|
|
Histone Acetyltransferase Inhibitor II
|
组蛋白乙酰转移酶 抑制剂II
|
932749-62-7
|
|
HA-100
|
1-(5-异喹啉磺酰基)哌嗪盐酸盐
|
84468-24-6
|
|
GSK 4027
|
化合物 T11495L
|
2079896-25-4
|
|
GSK4028
|
2079886-19-2
|
2079886-19-2
|
|
D-erythro-Sphingosine
|
D-鞘氨醇
|
123-78-4
|
|
PBIT
|
2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one
|
2514-30-9
|
|
AK-1
|
SIRT2 Inhibitor II, AK-1
|
330461-64-8
|
|
Gly-Arg-Gly-Asp-Ser
|
GLY-ARG-GLY-ASP-SER
|
96426-21-0
|
|
187-1, N-WASP inhibitor
|
|
380488-27-7
|
|
Dynamin inhibitory peptide
|
P4
|
251634-21-6
|
|
HSDVHK-NH2
|
P11
|
848644-86-0
|
|
DynaMin inhibitory peptide, myristoylated
|
MYR-GLN-PRO-PRO-ALA-SER-ASN-PRO-ARG-VAL-ARG-NH2
|
251634-22-7
|
|
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA
|
199807-33-5
|
199807-33-5
|
|
Vedolizumab
|
维多珠单抗
|
943609-66-3
|
|
Carbenoxolone disodium
|
甘珀酸钠
|
7421-40-1
|
|
Cyclo(-RGDfK)
|
CYCLO (RGDFK)
|
161552-03-0
|
|
Cyclo(-RGDfK) TFA
|
Cyclo (-RGDfK) 2,2,2-Trifluoroacetic acid
|
500577-51-5
|
|
Cyclo(RADfK)
|
整合素配体多肽Cyclo(Arg-Ala-Asp-d-Phe-Lys）
|
756500-23-9
|
|
iRGD peptide
|
iRGD肽
|
1392278-76-0
|
|
Gap 27
|
Gap 27
|
198284-64-9
|